British Patient Capital

British Patient Capital (BPC) is the UK’s largest domestic investor in venture and venture growth opportunities.

With more than £3bn of assets under management, BPC’s mission is to enable long-term investment in innovative UK companies led by ambitious entrepreneurs who want to build successful, world-class businesses. By focusing on the late-stage funding gap, BPC is helping to ensure high-growth UK companies have access to the right type of funding at the right time in their life-cycle, supporting them as they expand, create jobs, develop products and enter new markets. A subsidiary of British Business Bank, BPC invests on a commercial basis to deliver competitive returns and manage risk. As the largest domestic investor in UK venture and venture growth funds, BPC is drawing on its strong track record, established network of relationships, and experienced investment team to help ensure innovative UK Life Sciences companies have the patient capital they need to fulfil their potential as well as making cornerstone commitments to specialist venture growth funds to increase the availability of later-stage finance for high-potential UK life sciences companies.